Here's Why Bayer Would Be Overpaying for Monsanto

What is a major concern for investors regarding the Monsanto deal?

• Investors are worried about overpaying for Monsanto.

• The deal is the smallest M&A in recent years.

• The deal involves a merger with Syngenta.

• The deal is entirely funded by debt.

Why is the Monsanto deal considered unprecedented for a German company?

• It involves a merger with a pharmaceutical company.

• No German company has ever attempted a deal of this size.

• It is the first all-cash deal in Germany.

• It is the first time a German company is acquiring a US company.

What historical event is mentioned as a comparison to the Monsanto deal?

• The failed merger of Pfizer and Allergan.

• The acquisition of Syngenta by Chemchina.

• The merger of Daimler and Chrysler in 1997.

• The acquisition of Bayer by Monsanto.

What financial change is expected as a result of the Monsanto deal?

• The company will become debt-free.

• Net debt will increase from 7 billion to 17 billion.

• The company will issue no new shares.

• Net debt will decrease significantly.

What power do shareholders have regarding the Monsanto deal?

• They can demand a higher share price.

• They can veto the entire deal.

• They can force a merger with another company.

• They can refuse the capital raise.